Searched for
SAREPTA THERAPEUTICS
Dr Vinay Prasad's FDA exit in less than 3 months linked to Sarepta gene therapy controversy? Check detailsDr. Vinay Prasad, a controversial figure and critic of the FDA, resigned from his high-ranking position at the agency after less than three...
Vinay Prasad, US FDA's chief medical and science officer, departs agencyVinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to California and...
US stock market today dances near record heights: S&P 500 flirts with all-time high, Nasdaq soars on tech euphoria, Dow holds steady as Fed decision loomsUS stock market today trends analysis shows Wall Street moving with cautious optimism as the S&P 500 flirts with record highs and tech stoc...
US stock market futures surge in record-breaking tsunami as S&P 500, Nasdaq hit all-time highs and Dow rallies ahead of big tech earnings and Fed decisionUS stock market today started the week with rising optimism as Dow Jones, S&P 500, and Nasdaq futures climbed ahead of major earnings repor...
Sarepta shares fall 7% after gene therapy maker pauses Elevidys shipments in USShares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator's request to pau...
U.S. stock market hits fresh record highs—Dow, S&P 500, Nasdaq climb, driven by Verizon, Block, Cleveland‑Cliffs gainsUS Stock market today saw the Dow, S&P 500, and Nasdaq inch higher as Wall Street kicked off a packed week of Big Tech earnings and rising ...
U.S. stock futures rise as Dow, S&P 500, Nasdaq edge higher; Tesla and Alphabet earnings loom, Trump’s tariff deadline fuels global trade fearsU.S. stock futures rise as investors brace for a high-stakes week packed with Tesla and Alphabet earnings and growing anxiety over Trump’s ...
US equities end higher as oil prices pull back on truce hopesAmerican stock markets saw gains on Monday. This happened as oil prices decreased. Concerns about inflation decreased after attacks between...
US stock market futures climb as Dow, S&P 500, and Nasdaq rally ahead of Fed decision; Tesla, U.S. Steel surge while Sarepta crashes amid Israel-Iran tensionsUS stock market futures show Wall Street futures bouncing back, with Dow futures up 175 points after Friday’s heavy losses due to rising te...
Nasdaq ends lower as Nvidia drags the tech sector for second dayS&P 500 and Nasdaq closed slightly lower on Friday, impacted by Nvidia's decline. Market volatility was observed due to triple witching, wi...
S&P 500, Nasdaq lower as semiconductor shares weighAI chip firm Nvidia fell by 4.4%, following losses in the previous session that caused its market valuation to drop below Microsoft's. Othe...
Government plans to offer support for treatment of rare diseases"Accordingly, as these patients have already commenced treatment, Sarepta Therapeutics has committed, as per the communication received by ...
US stock market: Wall Street closes higher on eve of Fed decision; investors assess earnings"Today's move back into positive territory is on the growing consensus the Fed is more likely to hold off on any more rate hikes this year,...
Wall St wavers ahead of Fed decision; investors assess earningsThe Fed kicked off a two-day monetary policy meeting on Tuesday. At the end of the meet the central bank is widely expected to hold interes...
Wall St losses limited as Amazon gains on upbeat Cyber MondayThe Dow Jones Industrial Average fell 71.1 points, or 0.21%, at the open to 34,275.91
Finalise policy on rare diseases by March 31: High Court to CentreJustice Singh said she was issuing the direction to finalise the policy and operationalise the digital platform by March 31 as an affidavit...